Francesco Salvatore

Ceinge Biotecnologie Avanzate (Italy)

Papers

2

Total Citations

74

H-Index

2

About

Francesco Salvatore is a pioneering molecular geneticist whose work has fundamentally shaped our understanding of cystic fibrosis (CF) in Southern Italy. His primary research focuses on the molecular epidemiology of CF mutations, genotype-phenotype correlations, and the development of advanced diagnostic screening methodologies. Salvatore's major contributions include the discovery of five rare CF mutations peculiar to Southern Italy, significantly expanding the known mutational spectrum of the disease. His landmark 1999 study, which has garnered 49 citations, demonstrated that standard screening panels missed over 20% of CF alleles in this population, leading to improved diagnostic accuracy and patient care. He also developed an innovative semiautomated robotic procedure for mutation detection, described in his 1996 work (25 citations), which enhanced the efficiency and reliability of CF screening. This methodological advancement enabled comprehensive haplotype analysis and more precise phenotype characterization for patients with homozygous mutations. Salvatore's work has had lasting impact on genetic counseling, newborn screening programs, and clinical management of CF in Mediterranean populations, establishing him as a key figure in regional molecular diagnostics and personalized medicine for genetic disorders.

Research Focus

Key Achievements

2
H-Index
2
Papers
74
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
Detection of Five Rare Cystic Fibrosis Mutations Peculiar to Southern Italy: Implications in Screening for the Disease and Phenotype Characterization for Patients with Homozygote Mutations
49 citations · 1999
📈 Most Prolific Year: 1999 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Ceinge Biotecnologie Avanzate (Italy)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago